Last deal

$14.5M

Amount

Series B

Stage

27.07.2008

Date

2

all rounds

$21.6M

Total amount

General

About Company
Sierra Surgical Technologies develops minimally invasive surgical systems, with a focus on female sterilization.

Industry

Sector :

Subsector :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's flagship product, the Next-generation Advanced Tubal Occlusion (NATO) system, is designed to provide a non-permanent, easy-to-use method of female sterilization. It leverages NovaSure's endometrial ablation technology and requires minimal anesthesia, making it convenient for physicians and patients. Sierra Surgical also offers medical devices for spinal disorders, including surgical implants, biologics, and braces. Headquartered in Palo Alto, California, the company aims to meet the needs of patients, surgeons, and healthcare providers with its innovative solutions.